The personalized medicine news monitor, with an emphasis on the use of biomarkers in discovering new chemical entities and identifying specific patient populations.
Audience:   Corporate executives at drug developers, contract research organizations, and central laboratories employing or developing biomarker based techniques and therapies.

Key Topics: The use of biomarkers in discovering new chemical entities and identifying specific patient populations

Newsletter Frequency: Every Other Week

Email Subscribers: 13,500+

Monthly page views: 6,000

Reader Demographics

Region
North America - 69%
Europe - 14%
Asia - 10%
Australia/NZ - 1%
Other - 6%

View Rates

Enter your contact information to see current rates and packages.